seed
Stage
1
Investors
About
NeuroBionics is developing minimally-invasive endovascular neuromodulation technology using flexible, multifunctional fibers to treat neurological conditions like Parkinson's and depression, reducing the invasiveness of traditional deep brain stimulation.
Explore NeuroBionics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.